2F-NENDCK

2F-NENDCK (also known as CanKet, 2-fluoro-N-ethylnordeschloroketamine, 2'-fluoro-2-oxo-phenylcyclohexylethylamine, 2'-Fluoro-2-Oxo-PCE, and 2-FXE) is a recreational designer drug from the arylcyclohexylamine family, with dissociative…

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

2F-NENDCK (also known as CanKet, 2-fluoro-N-ethylnordeschloroketamine, 2'-fluoro-2-oxo-phenylcyclohexylethylamine, 2'-Fluoro-2-Oxo-PCE, and 2-FXE) is a recreational designer drug from the arylcyclohexylamine family, with dissociative effects presumably similar to those of ketamine. Its general effects, dissociative or otherwise, may deviate from other arylcyclohexylamines.

It was initially identified in Canberra, Australia in mid-August 2022 by the government-funded drug-testing service CanTEST. It has since been dubbed "CanKet" due to it originally being found in Canberra and being a structural analogue of ketamine. It has subsequently been discovered in Taiwan, China and New Zealand.

In April 2023, it was revealed by DrugsData.org that all of their previous samples of Fluorexetamine (3-FXE) actually contained 2F-NENDCK (2-FXE).

Text derived from https://en.wikipedia.org/w/index.php?oldid=1377587593 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

8 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.